New on-line recommendations on the management of hepatitis C will now be announced by the European Association for the Study of the Liver (EASL). These EASL recommendations reflect the approval of three new direct-acting antivirals (DAAs) during 2014 by the European Medicines Agency. It is estimated that approximately 185 million people are infected with HCV on a global scale, with approximately 150 million people living with chronic infection. In Europe, between ...
via Medindia Health News More READ
via Medindia Health News More READ
No comments:
Post a Comment